TRANSFORM Heart Failure with Reduced Ejection Fraction

首次发布于 2021 年 5 月 5 日

Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease

计划入组 95 人 · 首次发布于 2024 年 2 月 8 日

Ketones in Heart Failure With Reduced Ejection Fraction

计划入组 25 人 · 首次发布于 2024 年 1 月 8 日

Tovinontrine

C₂₁H₂₆N₆O₂

heart regeneration therapy (congestive heart failure)

Heart Failure(River Biomedics)

BERLIN HEART, INC.

United States

KEYSTONE HEART LTD

Israel

Heart Metabolics Ltd.

Ireland

Ivabradine's Impact on Heart Failure with Reduced Ejection Fraction: A Systematic Review and Meta-Analysis

Medera Advances SRD-001 Gene Therapy to Phase 2 Trial for Heart Failure with Reduced Ejection Fraction

FDA Approves Verquvo (vericiguat) for Chronic Heart Failure with Reduced Ejection Fraction